1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Short-read Sequencing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Short-read Sequencing Market, by Technology
8.1.1. Next-Generation Sequencing
8.1.1.1. Market Revenue and Forecast
8.1.2. Sanger Sequencing
8.1.2.1. Market Revenue and Forecast
9.1. Short-read Sequencing Market, by Workflow
9.1.1. Pre-Sequencing
9.1.1.1. Market Revenue and Forecast
9.1.2. Sequencing
9.1.2.1. Market Revenue and Forecast
9.1.3. Data Analysis
9.1.3.1. Market Revenue and Forecast
10.1. Short-read Sequencing Market, by Product
10.1.1. Instruments
10.1.1.1. Market Revenue and Forecast
10.1.2. Consumables
10.1.2.1. Market Revenue and Forecast
10.1.3. Services
10.1.3.1. Market Revenue and Forecast
11.1. Short-read Sequencing Market, by Application
11.1.1. Clinical Investigation
11.1.1.1. Market Revenue and Forecast
11.1.2. Oncology
11.1.2.1. Market Revenue and Forecast
11.1.3. Reproductive Health
11.1.3.1. Market Revenue and Forecast
11.1.4. Consumer Genomics
11.1.4.1. Market Revenue and Forecast
11.1.5. Agri genomics and Forensics
11.1.5.1. Market Revenue and Forecast
11.1.6. HLA Typing/ Immune System Monitoring
11.1.6.1. Market Revenue and Forecast
12.1. Short-read Sequencing Market, by End User
12.1.1. Academic Research
12.1.1.1. Market Revenue and Forecast
12.1.2. Hospital and Clinics
12.1.2.1. Market Revenue and Forecast
12.1.3. Clinical Research
12.1.3.1. Market Revenue and Forecast
12.1.4. Pharmaceutical and Biotechnology Companies
12.1.4.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Technology
13.1.2. Market Revenue and Forecast, by Workflow
13.1.3. Market Revenue and Forecast, by Product
13.1.4. Market Revenue and Forecast, by Application
13.1.5. Market Revenue and Forecast, by End User
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Technology
13.1.6.2. Market Revenue and Forecast, by Workflow
13.1.6.3. Market Revenue and Forecast, by Product
13.1.6.4. Market Revenue and Forecast, by Application
13.1.6.5. Market Revenue and Forecast, by End User
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Technology
13.1.7.2. Market Revenue and Forecast, by Workflow
13.1.7.3. Market Revenue and Forecast, by Product
13.1.7.4. Market Revenue and Forecast, by Application
13.1.7.5. Market Revenue and Forecast, by End User
13.2. Europe
13.2.1. Market Revenue and Forecast, by Technology
13.2.2. Market Revenue and Forecast, by Workflow
13.2.3. Market Revenue and Forecast, by Product
13.2.4. Market Revenue and Forecast, by Application
13.2.5. Market Revenue and Forecast, by End User
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Technology
13.2.6.2. Market Revenue and Forecast, by Workflow
13.2.6.3. Market Revenue and Forecast, by Product
13.2.7. Market Revenue and Forecast, by Application
13.2.8. Market Revenue and Forecast, by End User
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Technology
13.2.9.2. Market Revenue and Forecast, by Workflow
13.2.9.3. Market Revenue and Forecast, by Product
13.2.10. Market Revenue and Forecast, by Application
13.2.11. Market Revenue and Forecast, by End User
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Technology
13.2.12.2. Market Revenue and Forecast, by Workflow
13.2.12.3. Market Revenue and Forecast, by Product
13.2.12.4. Market Revenue and Forecast, by Application
13.2.13. Market Revenue and Forecast, by End User
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Technology
13.2.14.2. Market Revenue and Forecast, by Workflow
13.2.14.3. Market Revenue and Forecast, by Product
13.2.14.4. Market Revenue and Forecast, by Application
13.2.15. Market Revenue and Forecast, by End User
13.3. APAC
13.3.1. Market Revenue and Forecast, by Technology
13.3.2. Market Revenue and Forecast, by Workflow
13.3.3. Market Revenue and Forecast, by Product
13.3.4. Market Revenue and Forecast, by Application
13.3.5. Market Revenue and Forecast, by End User
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Technology
13.3.6.2. Market Revenue and Forecast, by Workflow
13.3.6.3. Market Revenue and Forecast, by Product
13.3.6.4. Market Revenue and Forecast, by Application
13.3.7. Market Revenue and Forecast, by End User
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Technology
13.3.8.2. Market Revenue and Forecast, by Workflow
13.3.8.3. Market Revenue and Forecast, by Product
13.3.8.4. Market Revenue and Forecast, by Application
13.3.9. Market Revenue and Forecast, by End User
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Technology
13.3.10.2. Market Revenue and Forecast, by Workflow
13.3.10.3. Market Revenue and Forecast, by Product
13.3.10.4. Market Revenue and Forecast, by Application
13.3.10.5. Market Revenue and Forecast, by End User
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Technology
13.3.11.2. Market Revenue and Forecast, by Workflow
13.3.11.3. Market Revenue and Forecast, by Product
13.3.11.4. Market Revenue and Forecast, by Application
13.3.11.5. Market Revenue and Forecast, by End User
13.4. MEA
13.4.1. Market Revenue and Forecast, by Technology
13.4.2. Market Revenue and Forecast, by Workflow
13.4.3. Market Revenue and Forecast, by Product
13.4.4. Market Revenue and Forecast, by Application
13.4.5. Market Revenue and Forecast, by End User
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Technology
13.4.6.2. Market Revenue and Forecast, by Workflow
13.4.6.3. Market Revenue and Forecast, by Product
13.4.6.4. Market Revenue and Forecast, by Application
13.4.7. Market Revenue and Forecast, by End User
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Technology
13.4.8.2. Market Revenue and Forecast, by Workflow
13.4.8.3. Market Revenue and Forecast, by Product
13.4.8.4. Market Revenue and Forecast, by Application
13.4.9. Market Revenue and Forecast, by End User
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Technology
13.4.10.2. Market Revenue and Forecast, by Workflow
13.4.10.3. Market Revenue and Forecast, by Product
13.4.10.4. Market Revenue and Forecast, by Application
13.4.10.5. Market Revenue and Forecast, by End User
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Technology
13.4.11.2. Market Revenue and Forecast, by Workflow
13.4.11.3. Market Revenue and Forecast, by Product
13.4.11.4. Market Revenue and Forecast, by Application
13.4.11.5. Market Revenue and Forecast, by End User
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Technology
13.5.2. Market Revenue and Forecast, by Workflow
13.5.3. Market Revenue and Forecast, by Product
13.5.4. Market Revenue and Forecast, by Application
13.5.5. Market Revenue and Forecast, by End User
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Technology
13.5.6.2. Market Revenue and Forecast, by Workflow
13.5.6.3. Market Revenue and Forecast, by Product
13.5.6.4. Market Revenue and Forecast, by Application
13.5.7. Market Revenue and Forecast, by End User
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Technology
13.5.8.2. Market Revenue and Forecast, by Workflow
13.5.8.3. Market Revenue and Forecast, by Product
13.5.8.4. Market Revenue and Forecast, by Application
13.5.8.5. Market Revenue and Forecast, by End User
14.1. BGI
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Agilent Technologies
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Thermo Fisher Scientific, Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. ProPhase Labs, Inc. (Nebula Genomics)
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Illumina, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Psomagen
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. QIAGEN
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Azenta US, Inc. (GENEWIZ)
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. PerkinElmer, Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Pacific Biosciences of California, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client